Page last updated: 2024-11-05

trifluoperazine and Dengue

trifluoperazine has been researched along with Dengue in 1 studies

Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Piccini, LE1
Castilla, V1
Damonte, EB1

Other Studies

1 other study available for trifluoperazine and Dengue

ArticleYear
Inhibition of dengue virus infection by trifluoperazine.
    Archives of virology, 2022, Volume: 167, Issue:11

    Topics: Animals; Antiemetics; Antipsychotic Agents; Antiviral Agents; Chlorocebus aethiops; Dengue; Dengue V

2022